About 300 reports

Other Anti-obesity Drugs

  • Obesity
  • China
  • United States
  • Prescription Drug Sales
  • Labour Force

Obesity - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Pipeline Review, H2 2020, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape. Obesity is defined as having an excessive amount of body fat. Obesity...

  • Endocrine Disease
  • Obesity
  • World

Abstract: - Global Anti-Obesity Drugs Market to Reach $5.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Anti-Obesity Drugs estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at a CAGR of 19.4% over the period 2020-2027. -...

  • Obesity
  • World
  • United States
  • China
  • Japan

Global Anti-obesity Drugs Market 2021-2025 The analyst has been monitoring the anti-obesity drugs market and it is poised to grow by $ 454.51 mn during 2021-2025 decelerate at a CAGR of 5% during the forecast period. Our reports on anti-obesity drugs market provides a holistic analysis, market size and forecast, trends,...

  • Obesity
  • World
  • Drug Approval
  • Overweight Prevalence

Obesity - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Obesity – Pipeline Review, H1 2020, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape. Obesity is defined as having an excessive amount of body fat. Obesity...

  • Endocrine Disease
  • Obesity
  • World

Abstract: - Global Bariatric (Obesity) Surgical Devices Market to Reach $2.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Bariatric (Obesity) Surgical Devices estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2027, growing at a CAGR of 5.8%...

  • Surgical Equipment
  • Obesity
  • World
  • China
  • United States

Anti-obesity Drugs Market Report Overview Anti-obesity Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Anti-obesity Drugs market types and applications. It is a focused study on Anti-obesity Drugs market space including global...

  • Obesity
  • World
  • Health Provider Density

Global Anti-obesity Drugs Market Forecast 2020-2030: Mechanism of Action, Innovator Drugs, Generics. Prescription Drugs, OTC, Duration of Therapy, Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor Agonists, Sympathomimetics, Short-term Drugs, Long-term Drugs The...

  • Obesity
  • World

Obesity:

  • Obesity
  • World
  • Overweight Prevalence
  • Prescription Drug Sales

A recent market study published by the company – “Weight Loss and Obesity Management: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2028,” consists of a comprehensive assessment of the most important market dynamics. By conducting a thorough research on the historical as well as current growth parameters of the weight loss and obesity...

  • Obesity
  • World
  • South Asia
  • Latin America
  • Retail Revenue
  • Online Retail Sales

The ongoing clinical trial research report- “2019 Abdominal Obesity Ongoing Clinical Trials Study” analyzes the current scenario of all active Abdominal Obesity trials across the world. The report presents top level analysis of global Abdominal Obesity clinical trials across countries, companies and universities. It is designed to provide...

  • Clinical Trial
  • Obesity
  • World
  • APAC

Obesity

  • Clinical Trial
  • Obesity
  • United States
  • China
  • Japan
  • Drug Approval
  • Overweight Prevalence

Major players in the anti-obesity drugs market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc. The global antiobesity market is expected to grow from $1.46 billion in 2020 to $2.4 billion in 2021 at a compound annual growth rate (CAGR) of 64.4%. The growth is mainly due to the companies rearranging...

  • Obesity
  • World
  • Overweight Prevalence

INCREASING INCIDENCES OF OBESITY AND DEGENERATIVE SPINAL CONDITIONS

  • Prosthesis
  • Obesity
  • Canada
  • Ireland
  • Overweight Prevalence
  • Paid Claims

Report Scope: This report aims to provide a comprehensive study of the global market for bariatric surgery, including services and devices. It provides a detailed description of the different types of bariatric procedures (invasive and noninvasive) and relevant devices. Bariatric procedures include sleeve gastrectomy,...

  • Obesity
  • World
  • Overweight Prevalence

Rising Number of Obesity Cases

  • Clinic
  • Genitourinary System Disease
  • Obesity
  • Urology
  • World
  • Fertility Rate
  • Overweight Prevalence

VII. ANTI-OBESITY DRUGS PRODUCER DIRECTORY

  • Pharmaceutical
  • Obesity
  • China
  • Prescription Drug Sales
  • Employment Costs

Obesity

  • Obesity
  • Epidemiology
  • World
  • Overweight Prevalence
  • Prescription Drug Sales

KEY FINDINGS The global intragastric balloon market is projected to register a CAGR of 12.14%, during the forecast period of 2019 to 2028. The market growth is driven by factors such as a vast obese population, a rise in government initiatives, short hospital stays, and quicker recovery time post intragastric ballooning,...

  • Obesity
  • Health Insurance
  • World
  • APAC
  • Overweight Prevalence

Other Anti-obesity Drugs

  • Obesity
  • China
  • United States
  • Labour Force
  • Industrial Production

Abstract: - The global market for Fatty Esters is projected to reach US$2.3 billion by 2025, driven by well-entrenched applications in the food, personal care and cosmetic sectors. The cosmetics and personal care sector represents one of the largest end-use markets, with growth supported by the steady rise in consumer...

  • Oleochemicals
  • Personal Care
  • Cosmetics
  • Biodiesel
  • Obesity
  • World
  • Health Expenditure
  • Biodiesel Production

Abstract: - Global Human Microbiome Market to Reach $964.5 Million by 2027 - Amid the COVID-19 crisis, the global market for Human Microbiome estimated at US$391 Million in the year 2020, is projected to reach a revised size of US$964.5 Million by 2027, growing at a CAGR of 13.8% over the analysis period 2020-2027....

  • Diabetes
  • Obesity
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • China
  • United States

Global Nutrigenomics Market: About this market This nutrigenomics market analysis considers sales from obesity, cardiovascular diseases, and cancer research applications. Our study also finds the sales of nutrigenomics in Asia, Europe, North America, and ROW. In 2019, the obesity segment had a significant market share,...

  • Genomics
  • Obesity
  • World
  • Overweight Prevalence

KEY FINDINGS The global non-alcoholic steatohepatitis (NASH) biomarker market is projected to grow with a CAGR of 20.65%, over the forecast period of 2021 to 2028. The market growth is mainly accredited to factors, such as, the rising NASH affected population, the surging awareness associated with non-alcoholic fatty liver...

  • Obesity
  • Hepatitis
  • Digestive System Disorder
  • Biomarker
  • Diabetes
  • Health Insurance
  • World
  • APAC
  • Overweight Prevalence
  • Diabetes Prevalence

Synthetic Peptide for Obesity and Type ## Diabetes – Drug Profile

  • Therapy
  • Diabetes
  • Dementia
  • Obesity
  • Pharmaceutical
  • World
  • Northern Europe
  • Indiana
  • Food Consumption
  • Prescription Drug Sales

Ineffective Esophageal Motility Treatment Market - Scope of the Report The latest publication on the global ineffective esophageal motility treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global ineffective...

  • Obesity
  • World

KEY FINDINGS The global bariatric surgery market is evaluated to record a CAGR of 9.56% during the forecast period of 2019-2028. The increasing prevalence of obesity worldwide, insurance coverage for surgeries, and government initiatives are augmenting the global market growth. MARKET INSIGHTS Bariatric...

  • Obesity
  • Health Insurance
  • World
  • Overweight Prevalence

The global intragastric balloons market is currently exhibiting strong growth. An intragastric balloon is a saline- or gas-filled inflatable silicone balloon that is temporarily placed inside the stomach for losing weight. It is inserted through a non-surgical endoscopic procedure to confine the amount of food stored...

  • Obesity
  • Research And Development
  • World
  • Overweight Prevalence

In July 2017, Antag Therapeutics ApS announced that it has secured a ## million USD Series A investment from Novo Seeds for their promising hormone treatment to fight obesity, diabetes and fatty liver disease and to support the development of their GIP (Gastric inhibitory polypeptide) antagonist program to combat diabetes, obesity and fatty liver disease.

  • Type 2 Diabetes
  • Drug Development
  • Therapy
  • Obesity
  • Dementia
  • Endocrine Disease
  • World
  • Diabetes Prevalence
  • Energy Consumption

Soft Tissue Anchors Market - Scope of the Report The latest publication on the global soft tissue anchors market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global soft tissue anchors market.The study offers detailed...

  • Health Insurance
  • Obesity
  • World
  • Overweight Prevalence